Alfredo Zurlo
Nessuna posizione attualmente
Profilo
Alfredo Zurlo served as Co-Managing Director at Glycotope GmbH.
He then worked as Chief Medical Officer at MOLOGEN AG from 2013 to 2016.
After that, he served as Chief Medical Officer at Scandion Oncology A.
Zurlo holds a doctorate degree from The American University of Rome.
Precedenti posizioni note di Alfredo Zurlo
| Società | Posizione | Fine |
|---|---|---|
| MOLOGEN AG | Direttore Tecnico/Scientifico/R&S | 31/03/2016 |
| SCANDION ONCOLOGY A/S | Direttore Tecnico/Scientifico/R&S | - |
Glycotope GmbH
 Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Amministratore Delegato | - |
Formazione di Alfredo Zurlo
| The American University of Rome | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MOLOGEN AG | Commercial Services |
| SCANDION ONCOLOGY A/S | Health Technology |
| Aziende private | 1 |
|---|---|
Glycotope GmbH
Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Health Technology |
- Borsa valori
- Insiders
- Alfredo Zurlo